Trial results show setrusumab reduces the incidence of fracture and increases bone density and formation. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...

Please provide your email address to receive an email when new articles are posted on . Children and adolescents with osteogenesis imperfecta who received IV neridronate therapy over 3 years saw gains ...

Please provide your email address to receive an email when new articles are posted on . The classification system associated with prenatally diagnosed osteogenesis imperfecta may be outdated. Modern ...

Add Yahoo as a preferred source to see more of our stories on Google. Maybe you heard about it after watching the Samuel L. Jackson movie "Unbreakable." Or maybe after binging Season 11 of "Grey's ...

Add Yahoo as a preferred source to see more of our stories on Google. Osteogenesis imperfecta type 3 is an inherited (genetic) bone disorder that is present at birth, according to John Hopkins ...

Osteogenesis imperfecta is a genetic disorder that affects the body’s connective tissues and often leaves people with fragile or brittle bones. On Tuesday, Sept. 17, Evenings with Genetics, a monthly ...

Mereo and Ultragenyx are collaborating to develop setrusumab, a sclerostin inhibitor, for treating patients with Osteogenesis Imperfecta. ASTEROID Phase 2 trial showed that setrusumab improved bone ...

A new study led by Baylor College of Medicine identifies an underlying mechanism of pathogenesis for osteogenesis imperfecta (OI) in human bone. The report, published in the Journal of Clinical ...

A COUPLE with brittle bone disease have been dubbed ‘selfish’ after welcoming a newborn with the same condition. Antwon and ...